Close
Back to ANGN Stock Lookup

Angion Biomedica (ANGN) – Management Comments

Apr 29, 2021 05:53 AM Angeion Corp (ANGN) and Vifor Pharma Report Complete Enrollment in Phase 2 Study of ANG-3777 for Cardiac-Surgery Associated Acute Kidney Injury
Mar 25, 2021 06:12 AM Angeion Corp (ANGN) Reports Complete Enrollment in Phase 2 Study of ANG-3777 for Acute Lung Injury in Patients with COVID-19 Associated Pneumonia

Back to ANGN Stock Lookup